Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 7 | 2019 | 166 | 1.260 |
Why?
|
| Benzoquinones | 6 | 2022 | 36 | 1.110 |
Why?
|
| Allyl Compounds | 5 | 2024 | 47 | 0.780 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2019 | 149 | 0.760 |
Why?
|
| Garlic | 4 | 2024 | 30 | 0.530 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1015 | 0.480 |
Why?
|
| Hydrolyzable Tannins | 3 | 2019 | 16 | 0.480 |
Why?
|
| Precancerous Conditions | 2 | 2024 | 82 | 0.440 |
Why?
|
| Lipopolysaccharides | 7 | 2018 | 220 | 0.420 |
Why?
|
| Receptors, CCR3 | 2 | 2009 | 10 | 0.420 |
Why?
|
| Neuroprotective Agents | 3 | 2022 | 245 | 0.420 |
Why?
|
| Pulmonary Alveoli | 2 | 2009 | 27 | 0.420 |
Why?
|
| Manganese Compounds | 1 | 2012 | 16 | 0.410 |
Why?
|
| Chlorides | 1 | 2012 | 56 | 0.410 |
Why?
|
| Chemokines, CC | 2 | 2009 | 51 | 0.400 |
Why?
|
| Sulfides | 3 | 2024 | 62 | 0.390 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 306 | 0.380 |
Why?
|
| Down-Regulation | 3 | 2022 | 435 | 0.370 |
Why?
|
| Antioxidants | 4 | 2024 | 416 | 0.370 |
Why?
|
| Cytokines | 4 | 2018 | 602 | 0.350 |
Why?
|
| Interleukin-4 | 1 | 2008 | 72 | 0.330 |
Why?
|
| Cell Survival | 7 | 2017 | 864 | 0.310 |
Why?
|
| Mitochondria | 1 | 2012 | 487 | 0.310 |
Why?
|
| Oxidative Stress | 2 | 2024 | 938 | 0.310 |
Why?
|
| RNA Interference | 1 | 2008 | 243 | 0.300 |
Why?
|
| Interferon-gamma | 5 | 2018 | 250 | 0.280 |
Why?
|
| RNA, Messenger | 5 | 2022 | 1207 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 1039 | 0.270 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 2231 | 0.260 |
Why?
|
| Biological Products | 2 | 2016 | 71 | 0.260 |
Why?
|
| Benzo(a)pyrene | 3 | 2024 | 126 | 0.250 |
Why?
|
| Gene Expression | 3 | 2022 | 674 | 0.250 |
Why?
|
| Anticarcinogenic Agents | 1 | 2024 | 65 | 0.230 |
Why?
|
| Disulfides | 2 | 2014 | 77 | 0.220 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 1502 | 0.210 |
Why?
|
| Phytotherapy | 1 | 2021 | 81 | 0.190 |
Why?
|
| Flavonoids | 1 | 2021 | 87 | 0.190 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 803 | 0.180 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 110 | 0.180 |
Why?
|
| Hydrogen Peroxide | 3 | 2022 | 190 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 448 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 65 | 0.170 |
Why?
|
| Mice | 7 | 2019 | 5913 | 0.170 |
Why?
|
| Cell Proliferation | 6 | 2023 | 1198 | 0.170 |
Why?
|
| Animals | 10 | 2019 | 15081 | 0.170 |
Why?
|
| Cell Line, Transformed | 2 | 2017 | 91 | 0.170 |
Why?
|
| NF-kappa B | 2 | 2018 | 339 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2017 | 115 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 356 | 0.150 |
Why?
|
| Butyric Acid | 1 | 2017 | 18 | 0.150 |
Why?
|
| Humans | 17 | 2024 | 37093 | 0.150 |
Why?
|
| Valproic Acid | 1 | 2017 | 16 | 0.150 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2017 | 16 | 0.150 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 123 | 0.150 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 11 | 0.140 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 10 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 169 | 0.140 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2017 | 38 | 0.140 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 409 | 0.140 |
Why?
|
| Manganese | 1 | 2017 | 87 | 0.140 |
Why?
|
| Proteomics | 2 | 2019 | 325 | 0.140 |
Why?
|
| Glioma | 1 | 2016 | 79 | 0.140 |
Why?
|
| Sepsis | 1 | 2016 | 80 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2021 | 426 | 0.130 |
Why?
|
| Nitrites | 1 | 2015 | 46 | 0.130 |
Why?
|
| Lysine | 1 | 2015 | 113 | 0.120 |
Why?
|
| Astrocytes | 1 | 2017 | 255 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 905 | 0.120 |
Why?
|
| Motor Activity | 1 | 2017 | 418 | 0.120 |
Why?
|
| Cell Line | 4 | 2019 | 1354 | 0.120 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 32 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 461 | 0.120 |
Why?
|
| Superoxides | 2 | 2016 | 53 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2016 | 453 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 352 | 0.110 |
Why?
|
| Inflammation | 1 | 2018 | 618 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 85 | 0.110 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 433 | 0.110 |
Why?
|
| Macrophages | 1 | 2016 | 439 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2023 | 16 | 0.110 |
Why?
|
| Proteome | 1 | 2014 | 144 | 0.110 |
Why?
|
| Estradiol | 1 | 2014 | 262 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 51 | 0.100 |
Why?
|
| PC12 Cells | 1 | 2012 | 93 | 0.100 |
Why?
|
| Carcinogens | 1 | 2012 | 124 | 0.100 |
Why?
|
| Apoptosis | 4 | 2024 | 1398 | 0.100 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2022 | 77 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2012 | 95 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 172 | 0.090 |
Why?
|
| DNA Damage | 3 | 2024 | 352 | 0.090 |
Why?
|
| Glucose | 1 | 2012 | 230 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 421 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2022 | 513 | 0.090 |
Why?
|
| Eosinophils | 1 | 2009 | 20 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2012 | 286 | 0.090 |
Why?
|
| Chemokine CCL24 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Glutathione | 2 | 2022 | 179 | 0.080 |
Why?
|
| Rats | 2 | 2016 | 3483 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 626 | 0.080 |
Why?
|
| Ligands | 1 | 2008 | 349 | 0.070 |
Why?
|
| Time Factors | 1 | 2012 | 1742 | 0.070 |
Why?
|
| Protein Array Analysis | 2 | 2017 | 25 | 0.070 |
Why?
|
| Cell Movement | 1 | 2009 | 571 | 0.060 |
Why?
|
| Female | 5 | 2024 | 20969 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 935 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2024 | 384 | 0.060 |
Why?
|
| Asthma | 1 | 2009 | 380 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2017 | 316 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 51 | 0.060 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2023 | 6 | 0.060 |
Why?
|
| Chemokines | 1 | 2023 | 97 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2023 | 207 | 0.050 |
Why?
|
| DNA Repair | 1 | 2024 | 188 | 0.050 |
Why?
|
| Catechin | 1 | 2022 | 31 | 0.050 |
Why?
|
| DNA | 1 | 2024 | 574 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 219 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 131 | 0.040 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2023 | 807 | 0.040 |
Why?
|
| Cerebellum | 1 | 2017 | 73 | 0.040 |
Why?
|
| Aging | 1 | 2022 | 664 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2016 | 17 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 112 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 90 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 109 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 131 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 155 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 550 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 290 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 24 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 502 | 0.030 |
Why?
|
| Chemoprevention | 1 | 2012 | 35 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1609 | 0.030 |
Why?
|
| Comet Assay | 1 | 2012 | 76 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2012 | 326 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 399 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 1908 | 0.020 |
Why?
|
| Male | 2 | 2017 | 20025 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1518 | 0.020 |
Why?
|